These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8707951)

  • 1. Monocyte activation in patients with non-seminomatous germ cell tumour of the testis before and after tumour eradication.
    Trulson A; Nilsson S; Venge P
    J Clin Pathol; 1996 May; 49(5):381-5. PubMed ID: 8707951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of non-seminomatous germ cell tumours (GCT).
    Paz-Ares L; Lianes P; Cortes-Funes H
    Ann Oncol; 1994 May; 5(5):457-62. PubMed ID: 7521207
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
    Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
    Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
    Sheinfeld J
    Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current therapeutic orientation toward testicular germ cell tumors].
    Catani M; De Milito R; Chiaretti M; Cortesi E; Anselmi W; Manili G; Tomei B; Terrinoni V; Bianchi G; Rengo M
    Minerva Urol Nefrol; 1999 Jun; 51(2):113-7. PubMed ID: 10429422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer.
    Christensen TB; Engbaek F; Marqversen J; Nielsen SI; Kamby C; von der Maase H
    Br J Cancer; 1999 Jul; 80(10):1577-81. PubMed ID: 10408402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of discordant beta hCG results by different assays in the management of non-seminomatous germ cell tumours of the testis.
    Summers J; Raggatt P; Pratt J; Williams MV
    Clin Oncol (R Coll Radiol); 1999; 11(6):388-92. PubMed ID: 10663328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
    Riedinger JM; Eche N; Chevreau C; Fargeot P
    Ann Biol Clin (Paris); 2008; 66(5):523-30. PubMed ID: 18957341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose methotrexate, vincristine and cisplatin as salvage treatment for relapsed non-seminomatous germ-cell cancer.
    Sleijfer S; Van der Graaf WT; Willemse PH; De Vries EG; Schraffordt Koops H; Mulder NH
    Anticancer Res; 1995; 15(3):1039-42. PubMed ID: 7544087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
    Guney S; Guney N; Sonmez NC; Ergenekon E
    Med Oncol; 2009; 26(2):136-42. PubMed ID: 18821067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group].
    Nakagawa S; Miki T; Akaza H; Ozono S; Okano T; Sonoda Y; Tsukamoto T; Terachi T; Naito K; Naito S; Nishiyama T; Nonomura N; Hara I; Hoshi S; Yoshida O
    Hinyokika Kiyo; 1999 Nov; 45(11):805-9. PubMed ID: 10637748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A young man with rapidly progressing dyspnoea and a mediastinal mass].
    van Spronsen DJ; van den Berkmortel FW; Bootsma GP; de Mulder PH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(46):2286-9. PubMed ID: 15586435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
    Kretschmar C; Kleinberg L; Greenberg M; Burger P; Holmes E; Wharam M
    Pediatr Blood Cancer; 2007 Mar; 48(3):285-91. PubMed ID: 16598761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases.
    Ushio Y; Kochi M; Kuratsu J; Itoyama Y; Marubayashi T
    J Neurosurg; 1999 Jan; 90(1):133-7. PubMed ID: 10413166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A; Biron P; Philip I; Blay JY; Droz JP
    Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
    de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
    Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].
    Drianno N; Robert M; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1997 Sep; 7(4):622-7. PubMed ID: 9410322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
    Mann JR; Raafat F; Robinson K; Imeson J; Gornall P; Sokal M; Gray E; McKeever P; Hale J; Bailey S; Oakhill A
    J Clin Oncol; 2000 Nov; 18(22):3809-18. PubMed ID: 11078494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.